A Multicentre Randomized Control Trial of Pericervical Tourniquet Versus Pericervical Tourniquet and Misoprostol in Reducing Blood Loss During Myomectomy in Katsina Metropolis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202403672013471

Enrollment

Registered

2024-03-28

Start date

2024-05-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine fibroids

Interventions

Misoprostol group

Pericervical haemostatic tourniquet

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Diagnosis of uterine fibroids with a treatment plan of abdominal myomectomy

Exclusion criteria

Exclusion criteria: Previous uterine surgery including caesarean section and previous myomectomy Bleeding disorder Uncontrolled hypertension and diabetes mellitus

Design outcomes

Primary

Measure	Time frame
Intraoperative blood loss of both groups;Need for intra-operative blood transfusion	—

Secondary

Measure	Time frame
Need for conversion to hysterectomy ;Duration of surgery;Need for post operative blood transfusion;Difference in the mean pre and postoperative haematocrits of both groups;Side effect profile to drugs used in both groups	—

Countries

Nigeria

Contacts

Public ContactAsmau Abdul

Federal Teaching Hospital Katsina

drabdul.asma@yahoo.com+2348065567547

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026